Published 20 hours ago • loading... • Updated 4 hours ago

Weight loss and diabetes jabs linked to potentially fatal side effect

The MHRA and Genomics England have launched the Yellow Card Biobank project to investigate pancreatitis cases linked to GLP-1 medicines in the UK.
This investigation follows hundreds of reports of acute and chronic pancreatitis among users of GLP-1 drugs, including Mounjaro, Wegovy, and Ozempic, some involving fatalities.
The MHRA is urging individuals hospitalized with acute pancreatitis while taking GLP-1 medicines to report via the Yellow Card scheme and provide saliva samples for genetic analysis.
Professor Matt Brown stated that GLP-1 medicines carry risks of serious side effects but many adverse reactions may have genetic causes allowing safer, personalised treatments.
The study seeks to identify patients with a genetic predisposition to medication side effects, aiming to prevent harmful reactions that are estimated to result in over £2.2 billion in annual hospital expenses for the NHS.

Insights by Ground AI

Does this summary seem wrong?

43 Articles

All

Left

Center

Right

Live Mint

Center

UK investigates weight-loss jab risks after many hospitalised with pancreatitis

The UK’s MHRA and Genomics England have launched a groundbreaking study to investigate whether genetics play a role in developing acute pancreatitis after taking GLP-1 weight-loss drugs like Ozempic, Mounjaro, and Wegovy.

in 26 years·New Delhi, India

Read Full Article

Green Matters

Lean Left

A Study Has Been Launched After Weight Loss Drug Users Report Pancreas Problems

If you or your family and friends take some weight loss medications, you'll want to read this. Some users are reporting pancreas problems.

4 hours ago·New York, United States

Read Full Article

The Epoch Times

Right

GPs Begin Prescribing Weight Loss Jabs to Obese Patients on NHS

Some people in England can now be prescribed the anti-obesity drug Mounjaro after the NHS rollout of the medication began on Monday. The repurposed antidiabetic drug, known generically as tirzepatide and made by pharmaceutical giant Eli Lilly, reduces blood sugar levels and slows digestion, effectively suppressing hunger and helping people lose weight. Family doctors in England can now prescribe the drug to severely overweight people who also su…

8 hours ago·New York, United States

Read Full Article